期刊文献+

高效液相色谱法同时测定银杏叶提取物中5种黄酮类成分 被引量:14

Simultaneous determination of five flavonols in extract of Ginkgo biloba by high performance liquid chromatography
下载PDF
导出
摘要 目的建立反相高效液相色谱法同时测定银杏叶提取物中5种黄酮类成分芦丁、槲皮苷、槲皮素、山奈酚、异鼠李素的含量。方法采用70%甲醇提取样品,以Kromasil C18为固定相,甲醇-0.1%甲酸水溶液为流动相,线性梯度洗脱,流速1.0 ml/min;柱温:40℃;检测波长:360 nm;结果芦丁、槲皮苷、槲皮素、山奈酚、异鼠李素的定量限分别为0.03、0.02、0.008、0.006、0.005 mg/L,芦丁、槲皮苷、槲皮素、山奈酚、异鼠李素分别在2.02-50.5、1.932-48.3、2.01-50.4、0.49-12.3、0.39-9.8 mg/L浓度范围内其峰面积与浓度的线性关系良好(r〉0.9992),回收率为86.5%-99.2%,日内精密度及日间精密度的变异系数分别小于2%、3%。结论本方法简单、准确,为银杏叶提取物中黄酮类成分的质量控制提供了依据。 Objective To describe a high performance liquid chromatographic (HPLC) method to quantitate five flavonol components in the extract of Ginkgo biloba (EGb). Methods The five flavonols of EGb were extracted with 70% methanol and separated by passing through a kromasil C18 column (250 ×4.6 mm, 5μm ) at 40℃ with a step linear gradient using methanol: 0. 1% formic acid at a flow rate of 1.0 ml/min. Results The limits of quantitation for rutin, quereitrin, quereetin, kaempferol and isorhamnetin were 0.03, 0.02, 0.008, 0.006 and 0.005 mg/L, respectively. This method was linear over the concentration ranges of 2.02 - 50.5, 1. 932 - 48.3, 2.01 - 50.4, 0.49 - 12, 3 and 0.39 - 9.8 mg/L respectively( r 〉0. 9992 ). The rates of recovery for the five components ranged 86.5% - 99.2%, with the coefficient of precision being less than 2% within one day and less than 3% between two days. Condusion The method is simple and accurate, and hence, can be validated as a means offering the basis for the quality control of flavonols in EGb .
出处 《徐州医学院学报》 CAS 2008年第5期307-310,共4页 Acta Academiae Medicinae Xuzhou
基金 江苏高校自然科学基金(07KJD360225)
关键词 高效液相 银杏叶提取物 high performance liquid chromatography extract of Ginkgo biloba
  • 相关文献

参考文献9

二级参考文献15

  • 1谢培山.关于银杏叶制剂的质量控制及质量标准的意见和商榷[J].中药新药与临床药理,1996,7(2):1-3. 被引量:11
  • 2游松.银杏的化学及药理研究进展[J].沈阳药学院学报,1998,5(2):142-142.
  • 3VAN BEEK TERRIS.Ginkgo biloba[M].Amsterdm:Hardwood Academc Publishers,2000.109-142.
  • 4梁逸曾 俞汝勤.分析化学手册(第十分册),化学计量学[M].北京:化学工业出版社,2001..
  • 5[1]Funfgeld E W, Rokan Ginkgo biloba. Resent Results in Pharmacology and Clinic. Springer-verlag Berlin, Heidelberg, NewYork,London, Paris, Tokyo,1988.
  • 6[2]McKenna D J, Jones K, Hughes K. Efficacy, Safety and Use of Ginkgo Biloba in Clinical and Preclinical Applications. Altern Ther Health Med, 2001,7(5) :70,88.
  • 7[3]Liu B, Anderson D, Ferry DR, et al. Determination of Quercetin in Human Plasma Using Reversed-phase High-performance Liquid Chromatography. J Chromatogr B Biomed Appl, 1995,666: 1,149.
  • 8[4]Watson D G, Oliveira E J. Solid-phase Extraction and Gas Chromatography-mass Spectrometry Determination of Kaempferol and Quercetin in Human Urine After Consumption of Ginkgo biloba Tablets. J chromatogr B Biomed Sci Appl, 1999,723(1-2) :203.
  • 9[5]Nielsen S E, Dragsted L O. Column-switching High-Performance Liquid Chromatographic Assay for the Determination of Quercetin in Human Urine with Ultraviolet Absorbance Detection. J Chromatogr B Biomed Sci Appl, 1998,707(1-2) :81.
  • 10谢培山.中药制剂色谱指纹图谱(图像)鉴别[J].中成药,2000,22(6):391-395. 被引量:161

共引文献406

同被引文献182

引证文献14

二级引证文献110

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部